Zemplar and cardiac arrest Patient Reports February 10, 2012

Zemplar Side Effects Report #5841717-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Aug 08, 2008. Female patient, 73 years of age, weighting 149.9 lb, was diagnosed with secondary hyperthyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with ALFACALCIDOL, LANTHANUM CARBONATE. Patient was hospitalized. Patient died on 08/06/2008.

Zemplar Side Effects Report #6028293-8
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 29, 2008. Female patient, 73 years of age, weighting 149.9 lb, was diagnosed with secondary hyperthyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with FOSRENOL. Patient was hospitalized. Patient died on 08/06/2008.

Zemplar Side Effects Report #5152733-X
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 06, 2006. Female patient, weighting 141.1 lb, was diagnosed with renal failure chronic, hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, bundle branch block right, cardiac arrest , left ventricular failure, mitral valve incompetence, pulmonary oedema, ventricular tachycardia. Zemplar dosage: unknown. During the same period patient was treated with TELMISARTAN, FUROSEMIDE, SORTIS. Patient was hospitalized. Patient died on 10/17/2006.

Zemplar Side Effects Report #5747929-X
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2008. Female patient, weighting 180.2 lb, was diagnosed with renal failure chronic, glaucoma , hypothyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: abasia, cardiac arrest , cardiac failure congestive, lung disorder, sinusitis . Zemplar dosage: unknown. During the same period patient was treated with CADUET, ATENOLOL, TIMOLOL MALEATE, SODPOLYSTSYENE, CYANOCOBALAMIN, LORAZEPAM, LEVOTHYROXINE, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient died on 03/15/2008.


Zemplar Side Effects Report #6089154-1
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 20, 2009. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary, hypothyroidism, anaemia, hyperlipidaemia, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , gastrointestinal haemorrhage. Zemplar dosage: unknown. During the same period patient was treated with THYROHORMONE, ARANESP, OMACOR, RENAGEL, PLAVIX. Patient died on 01/15/2009.

Zemplar Side Effects Report #6132349-9
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Mar 20, 2009. Female patient, 74 years of age, weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary, hypothyroidism, anaemia, hyperlipidaemia, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , gastrointestinal haemorrhage. Zemplar dosage: unknown. During the same period patient was treated with THYROHORMONE, ARANESP, OMACOR, RENAGEL, PLAVIX. Patient died on 01/15/2009.

Zemplar Side Effects Report #5176594-8
Zemplar side effect was reported by a Physician from GERMANY on Dec 06, 2006. Female patient, 72 years of age, weighting 227.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cellulitis , sepsis , thrombophlebitis. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ASPIRIN, PRAVASIN PROTECT, ISOSORBIDE DINITRATE, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE, GABAPENTIN, PHOSEX. Patient died on 09/01/2006.

Zemplar Side Effects Report #4918682-4
Zemplar side effect was reported by a Physician from SPAIN on Aug 12, 2005. Male patient, 72 years of age, was diagnosed with hyperparathyroidism secondary, renal failure chronic, tuberculosis , insomnia, dyspepsia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , hyperphosphataemia. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, ETHAMBUTOL DIHYDROCHLORIDE, RISPERIDONE, OMEPRAZOLE, LEVOFLOXACINO, ISONIAZIDA, LERCANIDIPINO. Patient died on 08/10/2005.

Zemplar Side Effects Report #4762916-6
Zemplar side effect was reported by a Consumer or non-health professional from SPAIN on Aug 24, 2005. Male patient, 71 years of age, was diagnosed with hyperparathyroidism secondary, renal failure chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , condition aggravated. Zemplar dosage: unknown. During the same period patient was treated with CALCIJEX, CLOPIDOGREL BISULPHATE, CALCIUM POLYSTYRENE SULFONATE, ZARATOR, CARVEDILOL, ALUMINUM HYDROXIDE GEL, RENAGEL. Patient died on 07/21/2005.


Zemplar Side Effects Report #6086171-2
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 18, 2009. Male patient, 70 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary, coronary artery disease , renal failure chronic, hyperphosphataemia, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , dyspnoea, orthopnoea. Zemplar dosage: unknown. During the same period patient was treated with DILATREND, FILICINE, FORSENOL, RENAGEL, HEPARIN LEO, NEORECORMON, VENOFER. Patient died on 02/17/2009.

Zemplar Side Effects Report #4940178-4
Zemplar side effect was reported by a Physician from AUSTRIA on Mar 04, 2006. Male patient, 68 years of age, weighting 142.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCITRIOL. Patient died on 01/29/2006.

Zemplar Side Effects Report #4986877-X
Zemplar side effect was reported by a Physician from AUSTRIA on Mar 04, 2006. Male patient, 68 years of age, weighting 142.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac arrest , diabetic complication, interstitial lung disease, lipomatosis, myocardial infarction, renal disorder. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCITRIOL. Patient died on 01/29/2006.

Zemplar Side Effects Report #5874869-8
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Sept 05, 2008. Male patient, 66 years of age, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , peripheral arterial occlusive disease. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, PENTOXIFYLLINE, DARBEPOETIN ALFA, ISOSORBIDE MONONITRATE, IRBESARTAN, AMIODARONE, ACETYLSALICYLIC ACID SRT, TITRALAC. Patient was hospitalized. Patient died on 06/09/2008.

Zemplar Side Effects Report #6026416-8
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 23, 2008. Male patient, 66 years of age, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , peripheral arterial occlusive disease. Zemplar dosage: unknown. During the same period patient was treated with LASIX, TARONTAL, ARANESP, MONOSORDIL, APROVEL, ANGORON, SALOSPIR, TITRALAC. Patient was hospitalized. Patient died on 06/09/2008.


Zemplar Side Effects Report #4749888-5
Zemplar side effect was reported by a Consumer or non-health professional from SPAIN on Aug 12, 2005. Male patient, 62 years of age, was diagnosed with hyperparathyroidism secondary, renal failure chronic, tuberculosis , insomnia, dyspepsia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cardiovascular disorder, hyperphosphataemia. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, ETHAMBUTOL DIHYDROCHLORIDE, RISPERIDONE, OMEPRAZOLE, LEVOFLOXACINO, ISONIAZIDA, LERCANIDIPINO. Patient died on 08/10/2005.

Zemplar Side Effects Report #5911231-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Oct 03, 2008. Male patient, 61 years of age, weighting 172.0 lb, was diagnosed with hyperparathyroidism secondary, blood phosphorus increased, anaemia, renal failure chronic and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with FORSENOL, EPOETIN ALFA, LEVOCARNITINE, CERNEVIT, FOLIC ACID, CLOPIDOGREL BISULPHATE. Patient died on 07/18/2008.

Zemplar Side Effects Report #6018614-4
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 19, 2008. Female patient, 60 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia, hypovitaminosis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with FORSENOL, PLAVIX, ZOLPIDEM, SUPERAMIN, CERNEVIT. Patient died on 12/03/2008.

Zemplar Side Effects Report #6099168-3
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Feb 20, 2009. Female patient, 60 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, hyperphosphataemia, hypovitaminosis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , pneumonia aspiration. Zemplar dosage: unknown. During the same period patient was treated with FORSENOL, PLAVIX, STILNOX, SUPERAMIN, CERNEVIT. Patient was hospitalized. Patient died on 12/03/2008.

Zemplar Side Effects Report #5794898-2
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on June 23, 2008. Female patient, 57 years of age, weighting 131.2 lb, was diagnosed with hyperparathyroidism secondary, diabetes mellitus, depression , hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with INSULIN, METHYLPREDNISOLONE, THEOPHYLLINE, PANTOPRAZOLE, VENLAFAXINE, TRAZODONE HYDROCHLORIDE, SIMVASTATIN. Patient died on 08/07/2007.


Zemplar Side Effects Report #4863350-0
Zemplar side effect was reported by a Consumer or non-health professional from VENEZUELA on Dec 12, 2005. Female patient, 29 years of age, weighting 78.26 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia , cardiac arrest , diarrhoea, haemodialysis, haemoptysis, hypotension, jaundice , pyrexia, sepsis . Zemplar dosage: unknown. Patient died on 12/05/2005.

Zemplar Side Effects Report #5200140-3
Zemplar side effect was reported by a Physician from GERMANY on Dec 28, 2006. Female patient, weighting 227.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cellulitis , sepsis , shock, thrombophlebitis. Zemplar dosage: unknown. During the same period patient was treated with FUROSEMIDE, ASPIRIN, PRAVASIN PROTECT, ISOSORBIDE DINITRATE, ZOLPIDEM TARTRATE, CITALOPRAM HYDROBROMIDE, GABAPENTIN, PHOSEX. Patient died on 09/01/2006.

Zemplar Side Effects Report #5117126-X
Zemplar side effect was reported by a Physician from GERMANY on Sept 19, 2006. Male patient, weighting 191.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , circulatory collapse, coronary artery stenosis. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 09/13/2006.

Zemplar Side Effects Report #5163116-0
Zemplar side effect was reported by a Physician from CZECH REPUBLIC on Nov 21, 2006. Male patient, weighting 110.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: blood pressure decreased, cardiac arrest , cardiac failure, fall , femur fracture, heart rate decreased, renal failure chronic. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 11/15/2006.

Zemplar Side Effects Report #5688299-5
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 26, 2008. Female patient, weighting 154.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FERRIGLUCONATE, FOLIC ACID, DARBEPOETIN ALFA. Patient died on 02/10/2007.


Zemplar Side Effects Report #6017466-6
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Dec 19, 2008. Male patient, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary, hypertension, anaemia, blood phosphorus abnormal, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with PLENDIL, FILICINE, RENAGEL, TENORMIN, MIMPARA, EVIOL, BIOTIN, NEUROBION. Patient was hospitalized. Patient died.

Zemplar Side Effects Report #6017789-0
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Dec 19, 2008. Female patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary, blood phosphorus abnormal, angina pectoris, coronary artery disease , hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with LASIX, CALCIORAL, RENAGEL, NITRONG, PLAVIX, DILATREND, COVERSIL, SALOSPIR. Patient died on 10/28/2008.

Zemplar Side Effects Report #6035170-5
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 12, 2009. Female patient, weighting 152.1 lb, was diagnosed with hyperparathyroidism secondary, blood phosphorus abnormal, angina pectoris, coronary artery disease , hypertension and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. During the same period patient was treated with LASIX, CALCIORAL, RENAGEL, NITRONG, PLAVIX, DILATREND, COVERSIL, SALOSPIR. Patient died on 10/28/2008.

Zemplar Side Effects Report #4894516-1
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2005. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, nephrogenic anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic valve stenosis, atelectasis, candidiasis, cardiac arrest , cerebral atrophy, cerebral ischaemia, coronary artery disease , coronary artery stenosis, delirium. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 10/15/2005.

Zemplar Side Effects Report #5040523-8
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 06, 2005. Male patient, weighting 185.2 lb, was diagnosed with hyperparathyroidism secondary, nephrogenic anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: aortic stenosis, cardiac arrest , coronary artery disease , delirium, depression , dysphagia, lobar pneumonia, pneumonia aspiration. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA, EPOETIN ALFA. Patient was hospitalized and became disabled. Patient died on 10/15/2005.


Zemplar Side Effects Report #5136381-3
Zemplar side effect was reported by a Physician from AUSTRIA on Sept 24, 2006. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac arrest , cardiogenic shock, multi-organ failure. Zemplar dosage: unknown. During the same period patient was treated with FOSRENOL, DARBEPOETIN ALFA, FOLIC ACID, NULYTELY, PRAVASTATIN, ASPIRIN, TRIAZOLAM, GLYCERYL TRINITRATE. Patient was hospitalized. Patient died on 08/29/2006.

Zemplar Side Effects Report #5680824-3
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 19, 2008. Female patient, 57 years of age, weighting 131.2 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , myocardial infarction. Zemplar dosage: unknown. Patient died on 08/07/2007.

Zemplar Side Effects Report #6047516-2
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 160.1 lb, was diagnosed with hyperparathyroidism, cardiac disorder, cardiac failure congestive, prostatomegaly, blood potassium decreased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, cardiac arrest , cardiac failure congestive, coronary artery disease , pericardial effusion, renal failure, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, CARVEDILOL, LASIX, METOPROLOL TARTRATE, NEPHROVITE, AVODART, UROXATAL. Patient died on 01/02/2009.

Zemplar Side Effects Report #6050406-2
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 19, 2009. Male patient, weighting 160.1 lb, was diagnosed with hyperparathyroidism, cardiac disorder, cardiac failure congestive, prostatomegaly, blood potassium decreased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: ascites, cardiac arrest , cardiac failure congestive, coronary artery disease , pleural effusion, renal failure, respiratory failure. Zemplar dosage: unknown. During the same period patient was treated with ASPIRIN, CARVEDILOL, LASIX, METOPROLOL TARTRATE, NEPHROVITE, AVODART, UROXATAL. Patient died on 01/02/2009.

Zemplar Side Effects Report #6075901-1
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2009. Male patient, weighting 256.2 lb, was diagnosed with hyperparathyroidism, vitamin supplementation, hypotension, reflux oesophagitis, hypertension, blood cholesterol increased, renal disorder, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , diabetes mellitus, hyperlipidaemia, malaise, myocardial infarction, renal failure. Zemplar dosage: unknown. During the same period patient was treated with SENSIPAR, FERROUS SULPHATE, MIDODRINE, ACIPHEX, GEMFIBROZIL, VYTORIN, RENAGEL, AVANDIA. Patient died on 10/26/2008.


Zemplar Side Effects Report #6078725-4
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Male patient, weighting 256.2 lb, was diagnosed with hyperparathyroidism, mineral supplementation, hypotension, gastrooesophageal reflux disease, hypertension, blood cholesterol increased, renal disorder, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , diabetes mellitus, hyperlipidaemia, malaise, myocardial infarction, renal failure. Zemplar dosage: unknown. During the same period patient was treated with SENSIPAR, FERROUS SULPHATE, MIDODRINE, ACIPHEX, GEMFIBROZIL, VYTORIN, RENAGEL, AVANDIA. Patient died on 10/26/2008.

Zemplar Side Effects Report #4772006-4
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on July 18, 2005. Female patient, weighting 109.1 lb, was diagnosed with hyperparathyroidism, anaemia prophylaxis, thrombosis prophylaxis, mineral supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , circulatory collapse, collapse of lung, malaise, respiratory arrest. Zemplar dosage: unknown. During the same period patient was treated with EPOGEN, IRON SACHHROSE, IRON SACHHROSE, ASPIRIN, CALCIUM CARBONATE. Patient was hospitalized. Patient died on 08/19/2005.

Zemplar Side Effects Report #5078818-4
Zemplar side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Female patient, weighting 88.18 lb, was diagnosed with glomerulonephritis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , cardiac failure congestive. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, ISOSORBIDE MONONITRATE, AMLODIPINE BESYLATE, LABETALOL, QUININE SULPHATE, BICARBONATE, CLONIDINE, LOSARTAN POTASSIUM. Patient was hospitalized. Patient died on 10/25/2005.

Zemplar Side Effects Report #5505664-7
Zemplar side effect was reported by a Health Professional from UNITED STATES on Oct 25, 2007. Female patient, weighting 196.2 lb, was diagnosed with calcium metabolism disorder, phosphorus metabolism disorder and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , respiratory arrest. Zemplar dosage: unknown. During the same period patient was treated with EPOETIN ALFA. Patient recovered.

Zemplar Side Effects Report #5981912-4
Zemplar side effect was reported by a Physician from KOREA, REPUBLIC OF on Dec 03, 2008. Male patient, 71 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest . Zemplar dosage: unknown. Patient died on 11/16/2008.


Zemplar Side Effects Report #5760209-1
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 29, 2008. Male patient, 63 years of age, weighting 256.2 lb, was diagnosed with blood glucose increased, thrombosis prophylaxis, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac arrest , electrocardiogram st segment elevation, loss of consciousness, rales, ventricular fibrillation. Zemplar dosage: 50MCG/ML. During the same period patient was treated with LANTUS OPTISET PRE, REPAGLINIDE, ORALVITE, ASPIRIN, SACCHARATED IRON OXIDE, FOLACIN, FUROSEMIDE, ATENOLOL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5783050-2
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on June 04, 2008. Male patient, 63 years of age, weighting 256.2 lb, was diagnosed with blood glucose increased, thrombosis prophylaxis, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac arrest , electrocardiogram st segment elevation, loss of consciousness, rales, ventricular fibrillation. Zemplar dosage: 50MCG/ML. During the same period patient was treated with LANTUS OPTISET PRE, REPAGLINIDE, ORALVITE, ASPIRIN, SACCHARATED IRON OXIDE, FOLACIN, FUROSEMIDE, ATENOLOL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5868830-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Aug 26, 2008. Male patient, 63 years of age, weighting 256.2 lb, was diagnosed with blood glucose increased, thrombosis prophylaxis, mineral supplementation, vitamin supplementation and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac arrest , electrocardiogram st segment elevation, loss of consciousness, rales, ventricular fibrillation. Zemplar dosage: 5 MICROGRAMS/MILLILITER. During the same period patient was treated with LANTUS OPTISET PRE, REPAGLINIDE, ORALVITE, ACETYLSALICYLIC ACID SRT, SACCHARATED IRON OXIDE, FOLACIN, FUROSEMIDE, ATENOLOL. Patient was hospitalized. Patient recovered.

Zemplar Side Effects Report #5678980-6
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 20, 2008. Female patient, weighting 154.3 lb, was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , hypercalcaemia. Zemplar dosage: unknown. During the same period patient was treated with CYANOCOBALAMIN, FERRIGLUCONATE, FOLIC ACID, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, MADOPAR. Patient died on 02/10/2007.

Zemplar Side Effects Report #4753950-0
Zemplar side effect was reported by a Consumer or non-health professional from BELGIUM on July 18, 2005. Female patient was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , malaise, respiratory arrest. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 08/19/2005.